Comparative Pharmacology
Head-to-head clinical analysis: TIMOPTIC versus TIMOPTIC IN OCUDOSE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: TIMOPTIC versus TIMOPTIC IN OCUDOSE.
TIMOPTIC vs TIMOPTIC IN OCUDOSE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Non-selective beta-adrenergic receptor antagonist (beta-blocker). Reduces intraocular pressure by decreasing aqueous humor production, likely via blockade of beta-2 receptors in the ciliary epithelium.
Timolol is a non-selective beta-adrenergic receptor antagonist (beta-1 and beta-2) that reduces intraocular pressure by decreasing aqueous humor production, likely by blocking beta-adrenergic receptors in the ciliary epithelium.
One drop of 0.25% or 0.5% solution in the affected eye(s) twice daily.
Instill 1 drop of 0.25% or 0.5% solution in the affected eye(s) twice daily.
None Documented
None Documented
Terminal elimination half-life is approximately 4-6 hours in healthy adults; prolonged in renal impairment.
Terminal elimination half-life is 4-6 hours in adults; prolonged to 8-12 hours in renal impairment.
Renal elimination: ~20% unchanged; biliary/fecal elimination: ~80% as metabolites.
Renal: approximately 80% as unchanged drug and metabolites; biliary/fecal: minor (less than 10%).
Category C
Category C
Ophthalmic Beta Blocker
Ophthalmic Beta Blocker